This site is intended only for healthcare professionals residing in Singapore
Lung cancer continues to be a leading cause of cancer mortality worldwide,1 impacting millions of people around the world. For patients diagnosed between 2011 and 2017 with NSCLC with distant metastases (SEER Stage), the 5-year survival rate was only 8%,2 highlighting the importance of early diagnosis, optimized treatment options and successful management of adverse events to improve patients' quality of life. Find out more about the recent advances in this field and what you can do to improve outcomes for your patients.
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
The information provided in this site is intended only for Healthcare Professionals in Singapore. The products discussed herein may have different product labelling in different countries. Pfizer Pte Ltd, Singapore is a subsidiary of Pfizer Inc, a pharmaceutical company committed to helping people improve their health by discovering and developing medicines.
Copyright © 2023 Pfizer Limited. All rights reserved.